Loading...
XNAS
XFOR
Market cap262mUSD
Oct 08, Last price  
2.79USD
1D
-0.71%
1Q
-36.73%
IPO
-99.89%
Name

X4 Pharmaceuticals Inc

Chart & performance

D1W1MN
XNAS:XFOR chart
P/E
—
P/S
7.49
EPS
—
Div yield, %
—
Shrs. gr., 5y
129.16%
Rev. gr., 5y
63.56%
Revenues
35m
+1,273.21%
000003,000,0000002,557,00035,113,000
Net income
-79m
L+111.48%
-13,218,000-22,975,000-33,877,000-33,284,999-52,807,000-62,131,000-88,696,000-93,867,000-101,167,000-37,450,000-79,199,000
CFO
-86m
L-34.59%
-10,816,000-21,639,000-27,871,000-25,420,000-48,055,000-58,818,000-70,905,000-77,102,000-96,512,000-130,901,000-85,618,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Actelis Networks, Inc. (ASNS) is a technology company specializing in advanced networking solutions. The company designs, develops, manufactures, and markets these solutions primarily for the Internet of Things (IoT) and telecommunications industries. Its operational reach is extensive, covering North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. Actelis' product portfolio includes a range of essential hardware such as Ethernet access devices, high-capacity aggregation switches, broadband amplifiers, and signal repeaters. Complementing its hardware, the company also offers proprietary element management systems software. Beyond products, Actelis provides comprehensive support services, including expert consulting, technical troubleshooting, remote assistance, training programs, product repairs, and crucial software updates. These solutions cater to a diverse array of critical sectors, such as intelligent traffic systems, educational and industrial campuses, airports, smart cities, railway networks, defense, energy, oil and gas, and water utilities. Founded in 1998, Actelis Networks is headquartered in Fremont, California.

Key people

Chairman of the Board · since 2019
Co-Founder, Chairman of the Board
Renato T. Skerlj
Senior Vice President - Research and Development · since 2019
Derek Meisner
General Counsel · since 2019
Adam S. Mostafa
Chief Financial Officer, Treasurer, Assistant Secretary · since 2019
Isaac Blech
Director · since 2019
Rene Russo
Director · since 2018
Murray W. Stewart
Director · since 2019
Independent Director · since 2017
IPO date
Nov 16, 2017
Employees
40
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
955 Massachusetts Avenue
4th Floor
Cambridge, MA 02139
US
Previous name
Arsanis, Inc.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT